Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


GREY:FRTX - Post by User

Comment by eskinny01on Mar 08, 2018 10:59am
181 Views
Post# 27683048

RE:RE:The AMG of 2018 is one to be seen and heard.

RE:RE:The AMG of 2018 is one to be seen and heard.JDavis17 - 10x revenue really isn't unheard of for innovative technologies.

There are a few industries that see these types of multiples regularly including biologics, pharma, cosmeceuticals and so on. Unilever, L'Oreal, Colgate and company have regularly paid 5-10x (in some cases 14-25x) for acquisition of cosmeceutical brands such as Skinceuticals, Dermalogica and so on.

Not sure if 10x is feasible in this industry or what the standards are but a willing buyer who sees potential in an innovative technology wouldn't put it out of the question.
Bullboard Posts